Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

NCT06854445 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large Cell B-lymphoma

Interventions

DRUG: TQB2825 Injection + Gemcitabine Hydrochloride for Injection + Oxaliplatin for Injection

Sponsor

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.